BEONE MEDICINES LTD. (ONC) Gross Margin
- Gross margin · 12 months: Value 88.89%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 88.89% | Gross profit / revenue. Period ending 2026-06-30. $5.45B ÷ $6.13B × 100 ≈ 88.89% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 5.45B USD | Gross Profit |
| Revenue | 6.13B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $5.45B | $6.13B | (m) | 88.89% |
| 2026-03-31 | $5.07B | $5.74B | (m) | 88.31% |
| 2025-12-31 | $4.67B | $5.34B | (m) | 87.49% |
| 2025-09-30 | $4.29B | $4.97B | (m) | 86.19% |
| 2025-06-30 | $3.90B | $4.56B | (m) | 85.52% |
| 2025-03-31 | $3.54B | $4.18B | (m) | 84.81% |
| 2024-12-31 | $3.22B | $3.81B | (m) | 84.41% |
| 2024-09-30 | $2.78B | $3.32B | (m) | 83.74% |
| 2024-06-30 | $2.63B | $3.10B | (m) | 84.98% |
| 2024-03-31 | $2.34B | $2.76B | (m) | 84.69% |
| 2023-12-31 | $2.08B | $2.46B | (m) | 84.55% |
| 2023-09-30 | (m) | $2.20B | $347.61M | (m) |
| 2023-06-30 | (m) | $1.81B | $327.84M | (m) |
| 2023-03-31 | (m) | $1.56B | $303.03M | (m) |
| 2022-12-31 | (m) | $1.42B | $286.48M | (m) |
| 2022-09-30 | (m) | (m) | $261.50M | (m) |
| 2022-06-30 | (m) | (m) | $232.37M | (m) |
| 2022-03-31 | (m) | (m) | $197.46M | (m) |
| 2021-12-31 | (m) | $1.18B | $164.91M | (m) |
| 2021-09-30 | (m) | $1.06B | $137.44M | (m) |
| 2021-06-30 | (m) | $947.04M | $111.15M | (m) |
| 2021-03-31 | (m) | $862.69M | $89.19M | (m) |
| 2020-12-31 | (m) | $308.87M | $70.66M | (m) |
| 2020-09-30 | (m) | $265.67M | $67.56M | (m) |
| 2020-06-30 | (m) | $224.73M | $66.55M | (m) |
| 2020-03-31 | (m) | $402.44M | $70.08M | (m) |
| 2019-12-31 | (m) | $428.21M | $71.19M | (m) |
| 2019-09-30 | (m) | $429.99M | $62.40M | (m) |
| 2019-06-30 | (m) | $434.05M | $51.00M | (m) |
| 2019-03-31 | (m) | $243.51M | $39.42M | (m) |
| 2018-12-31 | (m) | $198.22M | $28.70M | (m) |
| 2018-09-30 | (m) | $157.72M | (m) | (m) |
| 2018-06-30 | (m) | $323.74M | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $238.39M | (m) | (m) |
| 2017-09-30 | (m) | $220.21M | (m) | (m) |
| 2017-06-30 | (m) | $0.00 | (m) | (m) |
| 2017-03-31 | (m) | $393.00K | (m) | (m) |
| 2016-12-31 | (m) | $1.07M | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $8.82M | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $13.04M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.